Calcimagon-D3


Indications and Reactions:

Role Indications Reactions
Secondary
Breast Cancer 16.0%
Hypertension 12.0%
Systemic Lupus Erythematosus 10.0%
Coronary Artery Disease 8.0%
Inflammatory Bowel Disease 8.0%
Osteoporotic Fracture 8.0%
Ill-defined Disorder 6.0%
Osteoporosis 6.0%
Type 2 Diabetes Mellitus 4.0%
Arteriosclerosis 2.0%
Atrial Fibrillation 2.0%
Hashimoto's Thyroiditis 2.0%
Hypocalcaemia 2.0%
Osteopenia 2.0%
Polyarthritis 2.0%
Polymyalgia Rheumatica 2.0%
Pregnancy 2.0%
Product Used For Unknown Indication 2.0%
Prostate Cancer 2.0%
Trigeminal Neuralgia 2.0%
Somnolence 21.4%
Tooth Extraction 21.4%
Hypercalcaemia 14.3%
Colonic Stenosis 7.1%
Exposure During Pregnancy 7.1%
Liver Injury 7.1%
Osteonecrosis 7.1%
Therapeutic Response Decreased 7.1%
Weight Decreased 7.1%
Concomitant
Product Used For Unknown Indication 22.2%
Drug Use For Unknown Indication 17.6%
Osteoporosis 14.6%
Hypertension 7.4%
Rheumatoid Arthritis 5.6%
Renal Transplant 4.6%
Pain 4.3%
Depression 3.5%
Essential Hypertension 3.0%
Atrial Fibrillation 2.2%
Asthma 2.1%
Prophylaxis 1.8%
Systemic Lupus Erythematosus 1.6%
Hypothyroidism 1.5%
Bone Pain 1.4%
Chronic Obstructive Pulmonary Disease 1.4%
Prophylaxis Against Gastrointestinal Ulcer 1.4%
Constipation 1.3%
Breast Cancer 1.3%
Immunosuppression 1.3%
Vomiting 12.3%
Faecaloma 9.8%
Osteonecrosis 7.4%
Leukopenia 5.7%
Lower Limb Fracture 5.7%
Pathological Fracture 5.7%
Hepatic Encephalopathy 4.9%
Urinary Tract Infection 4.9%
Hepatocellular Injury 4.1%
Stupor 4.1%
Transaminases Increased 4.1%
Tremor 4.1%
Weight Decreased 4.1%
Angina Pectoris 3.3%
Bradycardia 3.3%
Drug Interaction 3.3%
Duodenal Ulcer Haemorrhage 3.3%
Femur Fracture 3.3%
Impaired Healing 3.3%
Orthostatic Intolerance 3.3%

Drug Data